)
Innovation is built on collaboration.
Onco AI-Med is a collaborative network of leading oncologists and cancer researchers that has its origins in the many scientific relationships we have established throughout our two-decade history. The network brings together the experiences, perspectives, and talents of experts from different countries and backgrounds to share ideas, explore new technologies, and advance the concept of precision medicine for the benefit of cancer patients all over the world.
Onco AI-Med advisory boardCancer research at the highest level
Members of the network are motivated by a shared passion for advancing precision oncology. We are convinced that by exchanging knowledge and ideas and working together across disciplines in an open and collaborative way, we can achieve our goals faster and more comprehensively. To ensure relevance and provide direction, the activities of the network are coordinated by an advisory board that includes some of the brightest experts in clinical translational oncology research today.
)
“The Onco AI-Med group has the power to unlock the secrets of cancer. I’ve never been prouder to work with a group of people!”
Dr. John Marshall
Chairman, Onco AI-Med advisory board
)
)
)
)
)
)
“The Onco AI-Med board is a fantastic example of what we can do with truly international cooperation.”
MediaLearn more about the work of Onco AI-Med.
)